Align Technology, Inc. · NASDAQ (us_market)
Healthcare · Medical Instruments & Supplies · United States
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-02-11$197.51 RISE2026-03-13$164.23 PEAK2026-04-22$196.05 70d | -16.8% 30d | Missed | Missed | — | — | +19.4% 40d | Missed |
DROP2025-07-28$207.19 RISE2025-09-25$124.88 PEAK2025-12-12$165.43 137d | -39.7% 59d | Missed | Missed | — | — | +32.5% 78d | Missed |
DROP2025-07-28$207.19 RISE2025-07-31$129.01 PEAK2025-08-22$149.57 25d | -37.7% 3d | Missed | Missed | — | — | +15.9% 22d | Missed |
DROP2025-01-23$234.89 RISE2025-05-23$170.80 PEAK2025-07-28$207.19 186d | -27.3% 120d | Missed | Missed | — | — | +21.3% 66d | Missed |
DROP2024-11-25$240.52 RISE2025-04-08$144.32 PEAK2025-07-02$196.98 219d | -40.0% 134d | Missed | Missed | — | — | +36.5% 85d | Missed |
DROP2024-09-19$257.17 RISE2024-10-31$205.03 PEAK2024-11-25$240.52 67d | -20.3% 42d | Missed | Missed | — | — | +17.3% 25d | Missed |
DROP2024-04-09$330.25 RISE2024-08-07$204.03 PEAK2024-09-19$257.17 163d | -38.2% 120d | Missed | Missed | — | — | +26.0% 43d | Missed |
DROP2023-07-27$385.31 RISE2023-11-01$183.21 PEAK2024-01-09$277.52 166d | -52.5% 97d | Missed | Missed | — | — | +51.5% 69d | Missed |
DROP2023-04-24$363.06 RISE2023-05-25$280.08 PEAK2023-07-27$385.31 94d | -22.9% 31d | Missed | Missed | — | — | +37.6% 63d | Missed |
DROP2023-02-02$359.88 RISE2023-03-28$305.29 PEAK2023-04-24$363.06 81d | -15.2% 54d | Missed | Missed | — | — | +18.9% 27d | Missed |
DROP2022-08-05$293.89 RISE2022-11-09$174.58 PEAK2023-02-02$359.88 181d | -40.6% 96d | 2022-11-07 $181.37 | 2023-02-02 $359.88 | 68Quality on Sale | 41Quality on Sale | +106.1% 85d | +98.4% Held 87d |
DROP2022-02-09$545.94 RISE2022-06-16$229.82 PEAK2022-08-05$293.89 177d | -57.9% 127d | 2022-04-28 $304.66 | 2022-08-05 $293.89 | 62Quality on Sale | 53Watch | +27.9% 50d | -3.5% Held 99d |
DROP2021-11-09$711.02 RISE2022-03-14$378.09 PEAK2022-03-22$457.03 133d | -46.8% 125d | Missed | Missed | — | — | +20.9% 8d | Missed |
DROP2021-09-23$727.11 RISE2022-01-27$455.62 PEAK2022-02-09$545.94 139d | -37.3% 126d | Missed | Missed | — | — | +19.8% 13d | Missed |
DROP2021-09-08$729.92 RISE2021-10-15$589.61 PEAK2021-11-09$711.02 62d | -19.2% 37d | Missed | Missed | — | — | +20.6% 25d | Missed |
1–15 / 17 1 / 2 | |||||||
Align Technology (NASDAQ:ALGN) executives highlighted product innovation, financing initiatives and international expansion as key growth drivers during a discussion at the 2026 Stifel Jaws & Paws Conference. Chief Financial Officer John Morici, joined by Shirley Stacy, vice president of financ
Align Technology, Inc. (NASDAQ:ALGN) is one of the best medical technology stocks to buy right now. On May 18, Stifel analyst Jonathan Block reaffirmed his Buy rating and $210 price target on Align Technology, Inc. (NASDAQ:ALGN) following a routine update to the firm’s financial model. Align Technology (ALGN): Record Aligner Shipments and Stifel Stays Bullish […]
Align Technology has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
The planned Hyderabad site will strengthen Align’s global operations.
The planned Hyderabad site will strengthen Align’s global operations.
Align Technology recently disclosed plans to invest about US$200,000,000 in a new clear-aligner manufacturing facility in Hyderabad, India, scheduled to open in 2027 and create more than 300 direct jobs as its first production site in the country. This expansion, alongside Align’s existing Global Capability Center and Innovation Center in Hyderabad, points to a deeper integration of Indian operations into its global supply chain and manufacturing footprint. Next, we’ll examine how this...
Align Technology recently disclosed plans to invest about US$200,000,000 in a new clear-aligner manufacturing facility in Hyderabad, India, scheduled to open in 2027 and create more than 300 direct jobs as its first production site in the country. This expansion, alongside Align’s existing Global Capability Center and Innovation Center in Hyderabad, points to a deeper integration of Indian operations into its global supply chain and manufacturing footprint. Next, we’ll examine how this...
HYDERABAD, India & TEMPE, Ariz., May 22, 2026--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced plans to open a new manufacturing facility in Hyderabad, India in 2027, create more than 300 direct jobs, and spend approximately $200 million in both capita
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners and services, and
Here is how Align Technology (ALGN) and Carlsmed, Inc. (CARL) have performed compared to their sector so far this year.
Here is how Align Technology (ALGN) and Carlsmed, Inc. (CARL) have performed compared to their sector so far this year.
BARCELONA, Spain & TEMPE, Ariz., May 21, 2026--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights of its 2026 Invisalign® EMEA Ortho Summit, which brought together approximately 400 orthodontists and dental professionals from across Europe, the Middle East, an
TEMPE, Ariz., May 20, 2026--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Techno
ALGN expands Invisalign worldwide and iTero Lumina leads scanner mix, backed by $1.06B cash, yet 2026 ASP expected down 1-2%.
ALGN expands Invisalign worldwide and iTero Lumina leads scanner mix, backed by $1.06B cash, yet 2026 ASP expected down 1-2%.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Align Technology, Inc.'s ( NASDAQ:ALGN ) recent earnings report didn't offer any surprises, with the shares unchanged...
Align Technology, Inc.'s ( NASDAQ:ALGN ) recent earnings report didn't offer any surprises, with the shares unchanged...
SAN CLEMENTE, Calif., May 12, 2026--Angelalign Technology Inc. (6699.HK) ("Angel") (http://www.angelaligner.com) today said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| ALGN | -2.21% | -7.44% | +12.04% | -3.31% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | -5.18% | -1.73% | +15.48% | -16.00% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 2.70M | $462.92M | 0.02% | Added+35.0% | 2026-03-31 |
| StateStreet | passive | 2.52M | $431.36M | 0.01% | Unchanged | 2026-03-31 |
| Wellington | fundamental | 71.6K | $12.28M | 0.00% | Trimmed-5.7% | 2026-03-31 |
| DEShaw | quant | 67.3K | $11.54M | 0.01% | Added+15.6% | 2026-03-31 |
| TwoSigma | quant | 43.7K | $7.49M | 0.01% | Trimmed-64.0% | 2026-03-31 |
| Bridgewater | macro | 9.9K | $1.70M | 0.01% | Trimmed-61.8% | 2026-03-31 |
| ARKK | disruptive | 6.4K | $1.09M | 0.01% | Trimmed-30.4% | 2026-03-31 |
| TRowePrice | fundamental | 97.8K | $16.77K | 0.00% | Trimmed-1.1% | 2026-03-31 |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | MORROW GEORGE J | Director | M Option exercise(deriv) | 1,745 | — | +$0 |
| 2026-05-22 | MORROW GEORGE J | Director | M Option exercise | 1,745 | — | +$0 |
| 2026-05-22 | Conroy Kevin T | Director | A Grant / award(deriv) | 1,836 | — | +$0 |
| 2026-05-22 | Conroy Kevin T | Director | M Option exercise(deriv) | 1,745 | — | +$0 |
| 2026-05-22 | Conroy Kevin T | Director | M Option exercise | 1,745 | — | +$0 |
| 2026-05-22 | LACOB JOSEPH | Director | A Grant / award(deriv) | 1,836 | — | +$0 |
| 2026-05-22 | LACOB JOSEPH | Director | M Option exercise(deriv) | 1,745 | — | +$0 |
| 2026-05-22 | LACOB JOSEPH | Director | M Option exercise | 1,745 | — | +$0 |
| 2026-05-22 | Dallas Kevin J | Director | A Grant / award(deriv) | 1,836 | — | +$0 |
| 2026-05-22 | Dallas Kevin J | Director | M Option exercise(deriv) | 1,745 | — | +$0 |
| 2026-05-22 | Dallas Kevin J | Director | M Option exercise | 1,745 | — | +$0 |
| 2026-05-22 | LARKIN C RAYMOND JR | Director | A Grant / award(deriv) | 2,448 | — | +$0 |
| 2026-05-22 | LARKIN C RAYMOND JR | Director | M Option exercise(deriv) | 2,326 | — | +$0 |
| 2026-05-22 | LARKIN C RAYMOND JR | Director | M Option exercise | 2,326 | — | +$0 |
| 2026-05-22 | Myong Anne | Director | A Grant / award(deriv) | 1,836 | — | +$0 |
| 2026-05-22 | Myong Anne | Director | M Option exercise(deriv) | 1,745 | — | +$0 |
| 2026-05-22 | Myong Anne | Director | M Option exercise | 1,745 | — | +$0 |
| 2026-05-22 | Poul Mojdeh | Director | A Grant / award(deriv) | 1,836 | — | +$0 |
| 2026-05-22 | Poul Mojdeh | Director | M Option exercise(deriv) | 1,745 | — | +$0 |
| 2026-05-22 | Poul Mojdeh | Director | M Option exercise | 1,745 | — | +$0 |
| 2026-05-22 | Saia Andrea Lynn | Director | A Grant / award(deriv) | 1,836 | — | +$0 |
| 2026-05-22 | Saia Andrea Lynn | Director | M Option exercise(deriv) | 1,745 | — | +$0 |
| 2026-05-22 | Saia Andrea Lynn | Director | M Option exercise | 1,745 | — | +$0 |
| 2026-05-22 | SIEGEL SUSAN E | Director | A Grant / award(deriv) | 1,836 | — | +$0 |
| 2026-05-22 | SIEGEL SUSAN E | Director | M Option exercise(deriv) | 1,745 | — | +$0 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-29upcoming | 2.61 | — | — |
| 2026-04-29 | 2.29 | 2.58 | +12.84% |
| 2026-02-04 | 2.97 | 3.29 | +10.81% |
| 2025-10-29 | 2.41 | 2.61 | +8.36% |
| 2025-07-30 | 2.57 | 2.49 | -3.26% |
| 2025-04-30 | 1.99 | 2.13 | +7.07% |
| 2025-02-05 | 2.45 | 2.44 | -0.37% |
| 2024-10-23 | 2.31 | 2.35 | +1.55% |
| 2024-07-24 | 2.30 | 2.41 | +4.56% |
| 2024-04-24 | 1.98 | 2.14 | +8.27% |
| 2024-01-31 | 2.18 | 2.42 | +11.22% |
| 2023-10-25 | 2.26 | 2.14 | -5.46% |
| 2023-07-26 | 2.04 | 2.22 | +9.09% |
| 2023-04-26 | 1.69 | 1.82 | +7.39% |
| 2023-02-01 | 1.53 | 1.73 | +12.71% |
| 2022-10-26 | 2.17 | 1.36 | -37.30% |